HIGHLIGHTS
- who: Christoffer A. Hagemann and collaborators from the Department of Medicine at rsholm, Denmark, Center for Clinical Metabolic Research, University have published the paper: A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity, in the Journal: PLOS ONE of 29/04/2022
- what: This study aimed to establish bioinformatics pipeline capable of defining and validating NAFLD biomarker candidates on paired hepatic global expression and plasma bioanalysis from individuals representing different stages of histologically confirmed NAFLD (no/mild moderate more advanced NAFLD). signatures were generated in patient cohort of 26 severely . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.